Skip to main content

6-K

SHL TELEMEDICINE LTD (SHMLF)

6-K 2024-09-19 For: 2024-09-19
View Original
Added on April 06, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2024

Commission File Number: 001-41641

SHL TELEMEDICINE LTD.

(Translation of registrant’s name into English)

90 Yigal Alon Street

Tel Aviv 67891, Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒             Form 40-F ☐


EXPLANATORY NOTE

On September 19, 2024, SHL Telemedicine Ltd. (the “Company”) issued a press release, a copy of which is furnished herewith as Exhibit 99.1. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546).


Exhibit Description
99.1 Press release, dated September 19, 2024, issued by the Company.
--- ---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SHL Telemedicine Ltd.
By: /s/ Amir Hai
Amir Hai
Chief Financial Officer

September 19, 2024



Exhibit 99.1

Invitation to half-year results 2024 conference call

Dear Madam or Sir,

SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN; NASDAQ: SHLT) invites you to its investor and media conference call to discuss the half-year results 2024. The conference call for investors, journalists, and analysts will be hosted by David Arnon, CEO, and Amir Hai, CFO, and has been scheduled for:

Date: Thursday, 26 September 2024

Time: 10.00 am CET / 11.00 am Israel Time

The conference call can be accessed live via the dial-in numbers:

From Europe +41 (0)58 310 50 00
From the UK +44 (0) 207 107 06 13
From the USA +1 (1) 631 570 56 13
From Israel +972 3763 1173

Other international numbers are available here.

After the presentation, there will be an open Q&A. The conference call will be held in English.

The press release, the half-year report and the presentations slides will be made available at the company website www.shl-telemedicine.com at 7.00 am CET on 26 September 2024.

For any additional support, please contact Fabienne Farner, phone +41 43 244 81 42 or e- mail shl@irf-reputation.ch.

We would be pleased to welcome you to this conference call.

    Yours sincerely,

The SHL IR and communications team